Week of Jul 20 – Jul 27
700 stories · 337 with likely market impact
By stock — what the news called up or down this week
Every name this week's movers tagged (ETFs need 2+ mentions). held = of the driving stories checked 1–2 weeks later, how many played out.
Tracked names — indirect reads
From the 19-stock weekly scan — supplier, rival, commodity, or policy reads the direct tagger missed.
| FDX▼down | ▼ down major | accumulation | FedEx reads down. Two stories tag FDX directly (55, 57), both down on the Houthi/Red Sea tanker attacks. The dominant driver, though, is indirect: the entire week is an oil/fuel shock (Brent $92 to $100-105, Hormuz flows collapsing) with jet fuel and especially diesel spiking hardest (line 115 diesel past $176/bbl outpacing Brent; 188 Russia diesel ban; 194 record European diesel margins). Fuel is FedEx's single largest variable cost across both Express air and Ground diesel fleets, and line 143 (American Airlines guiding 2026 EPS to zero on fuel up 83%, JETS:down in nearly every oil story) confirms the air-transport read-through. Layered on top is broad tariff escalation (50-52, 84, 116, 158, 179, 181) that compresses the cross-border parcel and freight volumes FedEx moves, with XLI:down on line 50. Late-week Iran de-escalation (59, 147, 152, 186) and a US-China tariff-cut plan (227) lift JETS and are a modest offset, but they do not reverse the week. Strength is major because the negative pressure hits FedEx's key cost sensitivity and accumulates across dozens of oil, diesel, and tariff stories rather than resting on the two direct FDX tags alone. |
| AAPL▼down | ▼ down moderate | accumulation | Every explicit AAPL tag in the week (lines 122, 137, 187) is `down`, and they are independent cost-side hits — TSMC foundry price increases, Qualcomm chip price increases, and a multi-year memory shortage (reinforced by the ADATA/CXMT/Micron memory-tightening cluster). These accumulate on Apple's bill-of-materials with no offsetting Apple-specific positive. Layered on top is a uniformly negative macro backdrop: a $797B Mag-7 rout (AAPL moves with QQQ/SPY, both down across dozens of stories), broad Trump tariffs raising China/India supply-chain and import-cost risk, and $100 oil driving 30Y yields above 5% with rate-hike fears that compress megacap multiples. Direction is clearly down. It reads moderate rather than minor because multiple independent input-cost stories stack with the macro drag, but not major because there is no single Apple-specific shock this week (no earnings, product, or regulatory event) — the read is indirect and cumulative. |
| DE▼down | ▼ down moderate | accumulation | Deere is never tagged directly in the week's movers, so the read is entirely indirect via its known drivers: equipment-financing rate sensitivity, farm economics, input costs, and trade. Two strong, repeatedly-recurring bearish macro forces dominate: (1) a persistent surge in long-end Treasury yields (30-yr above 5% for weeks, mortgage rates jumping, explicit rate-hike fears), which raises the cost of DE's captive-financed, big-ticket ag and construction equipment and pressures customer capex; and (2) a broad tariff/trade-war regime (10-12.5% on 60 partners plus a 50% Canada tariff, retaliation and lawsuits, XLI:down), which threatens an export-exposed farm-and-construction industrial and risks farm-export retaliation. Higher diesel/gasoline prices add a modest drag on farmer operating margins. Against this sits a lighter bullish ag-commodity tailwind (grain carrier sunk off Odesa lifting grain/fertilizer names, ADM/NTR/MOS up) and slightly cheaper aluminum from the 50% tariff cut. The bearish rate-plus-tariff cluster is larger, repeats across many headlines (accumulation), and outweighs the ag tailwind, yielding a net moderate-down read rather than major given there is no direct DE catalyst and real offsets exist. |
| UNP▼down | ▼ down moderate | accumulation | No story names UNP directly, so the read is entirely indirect. Two macro themes dominate the week and both hurt a fuel-intensive US Class I railroad. First, a large and sustained oil/diesel shock: Brent to $100+ across dozens of Hormuz/Houthi stories, ULSD futures past $176, record diesel refining margins, and Russia's diesel export ban. Diesel is UNP's biggest cost after labor, and fuel surcharges recover it only with a lag, so a spike of this size compresses margins near-term. The American Airlines guidance cut on an 83% fuel surge confirms the channel is live for fuel-heavy transports. Second, a broad tariff escalation: a 50% tariff on Canadian goods with USMCA disruption plus 10-12.5% duties on 60 partners cuts exactly the cross-border auto/intermodal freight UNP carries through its Mexico and Canada gateways (EWC, GM, F, STLA all down; XLI down). Layered on top, the oil-driven Treasury selloff and rate-hike fears pressure cyclical transports generally. The grain-carrier/ag stories are the only ambiguous input and are far smaller. Because many independent stories point the same way (fuel up, trade down, rates up) rather than one big catalyst, this is an accumulation read, which is why I rate it moderate down rather than minor despite the absence of any rail-specific headline. |
| BA▼down | ▼ down small | accumulation | No direct Boeing headline appears this week. Read is driven by two offsetting indirect channels. Negative: a sustained oil spike ($95-$105 Brent) with Hormuz/Red Sea disruption puts JETS down across dozens of stories and pushes American Airlines to guide 2026 earnings to zero on 83% higher fuel costs (line 143), which stresses BA's airline customers and their capacity to order/finance aircraft, BA's largest and highest-margin franchise. Positive: the Iran conflict drives a rising defense-spend regime (Pentagon $67B supplemental, line 210; Lockheed $65B orders, line 140) that lifts the defense complex ITA/LMT/RTX/GD/NOC, benefiting BA's defense unit. The airline/fuel drag is higher-frequency and hits the bigger commercial segment, while the defense tailwind is sector-diffuse and touches BA's smaller, historically troubled defense arm. Net: a mild negative lean built from accumulation of many oil/airline-demand stories rather than any single BA catalyst. |
| CAT▼down | ▼ down small | No story names Caterpillar directly; all exposure is indirect and the signals partly offset. Bearish weight is larger this week: broad new tariffs on 60 partners plus a 50% Canada tariff and retaliation hit a global industrial with heavy steel/component input costs and large ex-US sales (XLI explicitly marked down), while a sharp rate spike (30Y >5%, 10Y >4.7%, mortgage 6.58%, rate-hike fears) is a direct headwind for CAT's core construction and capital-goods end markets, layered over broad risk-off from the oil shock. Offsetting tailwinds exist but are more diffuse: the AI data-center power buildout (GE Vernova record backlog, Hut 8/IREN, OpenAI Georgia, hyperscaler capex) supports CAT gensets/Solar Turbines, sustained $95-100 oil supports upstream E&P and mining/energy equipment demand, and US fab/smelter onshoring aids domestic construction. Net a slight down read; signals conflict rather than accumulate, so strength is minor and not a clean directional bet. | |
| CEG~mixed | ~ mixed small | accumulation | No story tags CEG directly. As a nuclear IPP levered to AI data-center power demand and to gas/power prices, but also a long-duration bond-proxy utility, CEG sits between two opposing threads this week. Bullish, indirect: a heavy cluster of AI data-center buildout stories (Alphabet $205B capex, OpenAI's $30B/$750B Georgia data center, GE Vernova record orders on data-center demand, Hut 8/Meta/Nvidia-SK sites) all imply rising electricity load; #124 even tags SO:up, the cleanest utility read-through, and Hormuz cutting European LNG 33% (LNG:up) supports higher power prices that lift merchant-nuclear margins. Bearish, more direct: the dominant, most-repeated macro theme is the oil spike driving a bond rout, with the 30-year above 5% for 29 days and #218 explicitly tagging XLU:down. That rate move is the more forcefully and repeatedly signaled force and hits capital-intensive, bond-like power generators like CEG directly on valuation. The demand tailwind is structural but reaches CEG only indirectly through capex/chip framing, while the rate headwind is broad-based and tagged against utilities. Net read is mixed with a slight downward tilt from the accumulated rate signal, but strength is minor given no direct CEG mention and genuinely offsetting drivers. |
| JPM▲up | ▲ up small | accumulation | No story names JPMorgan and there is no JPM ticker in the digest, so the read is entirely indirect via the XLF financials-sector tag. The dominant, repeated signal is a Treasury selloff / rate-hike theme (lines 39, 95, 127, 146, 218), each explicitly tagged XLF:up. Higher yields and a rate-hike regime lift net interest income for a money-center bank like JPM, and the tagger consistently marks financials up on these stories even as SPY sells off. That XLF:up signal accumulates across at least five separate rate stories over the week, which is what drives the read rather than any single event. Countervailing forces exist: pervasive SPY:down from the oil shock, the multi-country tariff waves (recession/credit-loss risk), Mag7 selloff beta, and Asian deleveraging (KOSPI -30%, margin-debt unwinds) all pressure a bank's trading and credit book. But none of those carry a JPM or XLF:down tag, so the net skews modestly positive. Strength is minor because the effect is second-order (rate channel) and partly offset by broad risk-off; direct is false; accumulation is true because it is the pile-up of XLF:up rate stories, not one catalyst. |
| LLY▼down | ▼ down small | accumulation | No story in the digest names Eli Lilly or carries an LLY tag, so any read is indirect and weak. The only genuinely pharma-relevant catalysts are (1) Trump's 100%/200% tariff on generic drug imports, explicitly tagged XLV:down, and (2) two FDA-panel votes broadening pharmacy compounding of peptides (BPC-157 and six peptides), both tagged only HIMS:up. Both lean mildly negative for branded pharma sentiment: the generic-drug tariff creates a drug-policy/tariff overhang on the healthcare sector (XLV:down) even though it targets generics, not LLY's US-heavy innovator/GLP-1 franchise; broadened compounding is a mild pricing-power negative for peptide drugmakers, though these specific peptides are not the GLP-1s (tirzepatide) that drive LLY. Layered on top is a broad risk-off tape from the oil spike and surging Treasury yields (repeated SPY:down), a modest valuation headwind partly offset by pharma's defensive character in a risk-off/high-oil regime. Net: a minor, indirect, accumulated downward tilt driven by drug-policy sector overhang plus market beta, with no direct LLY catalyst. |
Week of Jul 20 – Jul 27
700 stories · 337 with likely market impact